Subscribe to stay informed!
Malvern-based Recro Pharma saw its stock plunge by more than 34 percent after the Food and Drug Administration rejected its new drug application for…
Recro Pharma’s latest drug test felt more like a shot of adrenaline than a sigh of relief when patients noted they were well aware…
Before we send you to this site, please subscribe to our daily newsletter.